Hasil Pencarian - Chang-Ching Lin

  • Menampilkan 1 - 6 hasil dari 6
Perbaiki Hasil
  1. 1
    Design of a Compact Multiband Monopole Antenna with MIMO Mutual Coupling Reduction

    Design of a Compact Multiband Monopole Antenna with MIMO Mutual Coupling Reduction oleh Chang-Keng Lin, Ding-Bing Lin, Han-Chang Lin, Chang-Ching Lin

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Rank-Based Comparative Research Flow Benchmarking the Effectiveness of AHP–GTMA on Aiding Decisions of Shredder Selection by Reference to AHP–TOPSIS

    Rank-Based Comparative Research Flow Benchmarking the Effectiveness of AHP–GTMA on Aiding Decisions of Shredder Selection by Reference to AHP–TOPSIS oleh Zheng-Yun Zhuang, Chang-Ching Lin, Chih-Yung Chen, Chia-Rong Su

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Study of Out-Of-Hospital Access to HIS System: A Security Perspective

    Study of Out-Of-Hospital Access to HIS System: A Security Perspective oleh Chih-Yung Chen, Yi-Chang Hsu, Chang-Ching Lin, Jeyhun Hajiyev, Chia-Rong Su, Ching-His Tseng

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer

    Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer oleh Kyung-min Lee, Angel L. Guerrero-Zotano, Alberto Servetto, Dhivya R. Sudhan, Chang-Ching Lin, Luigi Formisano, Valerie M. Jansen, Paula González-Ericsson, Melinda E. Sanders, Thomas P. Stricker, Ganesh Raj, Kevin M. Dean, Reto Fiolka, Lewis C. Cantley, Ariella B. Hanker, Carlos L. Arteaga

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer

    PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer oleh Chang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, Lei Guo, Yunpeng Gao, Emmanuel Bikorimana, Andrew Lemoff, Yisheng V. Fang, He Zhang, Yanfeng Zhang, Dan Ye, Isabel Soria-Bretones, Alberto Servetto, Kyung-min Lee, Xuemei Luo, Joseph J. Otto, Hiroaki Akamatsu, Fabiana Napolitano, Ram Mani, David W. Cescon, Lin Xu, Yang Xie, Joshua T. Mendell, Ariella B. Hanker, Carlos L. Arteaga

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    R26R-GR: a Cre-activable dual fluorescent protein reporter mouse.

    R26R-GR: a Cre-activable dual fluorescent protein reporter mouse. oleh You-Tzung Chen, Ming-Shian Tsai, Tsung-Lin Yang, Amy Tsu Ku, Ke-Han Huang, Cheng-Yen Huang, Fu-Ju Chou, Hsiang-Hsuan Fan, Jin-Bon Hong, Shuo-Ting Yen, Wei-Le Wang, Chang-Ching Lin, Yu-Chen Hsu, Kang-Yi Su, I-Chang Su, Chuan-Wei Jang, Richard R Behringer, Rebecca Favaro, Silvia K Nicolis, Chung-Liang Chien, Shu-Wha Lin, I-Shing Yu

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: